Nothing Failed: Why Each Injection Buys Less Time Than the One Before

What this video covers

• Why an image-guided injection or radiofrequency ablation blocks pain signals without changing what is driving them
• How obesity, insulin resistance, and high blood sugar add load to the joint. How they keep low-grade inflammation running through the body and slow tissue healing
• What the IDEA randomized trial found when it put intensive diet and exercise up against exercise alone. The patients were overweight and obese older adults with knee osteoarthritis. And how large the pain difference really was: about 1.1 points on a 20-point scale
• What the Cochrane review of multidisciplinary biopsychosocial rehabilitation shows for chronic low back pain. And why its own authors call the benefit modest
• Which parts of an integrative approach are established care (exercise, weight loss). And which are still adjunctive or emerging. One example: the same ACR/Arthritis Foundation guideline conditionally recommends against fish oil. Fish oil is the closest graded comparison to pro-resolving mediator supplements
• The real risks, stated plainly. Bleeding, infection, nerve injury, epidural hematoma or abscess. Dural puncture and headache. The rare but serious neurologic events the FDA has warned about with epidural corticosteroid. Post-ablation neuritis after radiofrequency. And several days of higher blood sugar after corticosteroid if you have diabetes
• The rules as they stand. A ketogenic diet is a dietary intervention, not an FDA-regulated product. It has not been tested alongside interventional pain care. Pro-resolving mediator products are sold as supplements without premarket review. They can raise bleeding risk on anticoagulants or antiplatelet agents. And 660 to 850 nm light devices are cleared only for temporary relief of minor muscle and joint pain and stiffness
• MEDICAL DISCLAIMER: This content is for educational purposes only and is not medical advice. It does not substitute for professional diagnosis or treatment. Always consult a licensed healthcare provider regarding your condition. Viewing this video does not establish a doctor-patient relationship.

Pain injections stop working over time because the needle interrupts a nerve, not what drives the pain. While a block quiets the wire, extra body weight keeps loading the joint. Fat tissue keeps inflammation running. High blood sugar keeps slowing repair. So each injection buys less time than the one before.

Three injections. Every one of them worked. The first bought four months. The second, three. The third, six weeks — and then the knee was grinding on the stairs again. Nothing failed. The needle went exactly where it was supposed to go. The pain came back anyway, because what makes it was never on the fluoroscope (the live X-ray) and was never the target of the procedure.

That is not a story about a bad injection. It is not a story about a patient who did something wrong. It is a story about what a procedure is built to do, and what it was never built to do. This article explains what a block actually interrupts. It covers what keeps running underneath while the block is working. And it covers the part almost nobody says out loud: exactly how strong the evidence is for the other half of the plan, graded one piece at a time.

One boundary first, because it governs every sentence below. Everything cited here covers knee and hip osteoarthritis, and nonspecific low back pain that has lasted longer than twelve weeks. Nothing else. Do not let anyone stretch it further — this article included.

What does a pain injection actually do?

Two procedures from this series make the point cleanly.

A genicular nerve block deposits local anesthetic on the nerve branches leaving the knee capsule. For the upper inner and upper outer branches, the spot is where the thigh bone’s shaft meets its rounded ends (the femoral shaft and condyles). For the lower inner branch, it is the top of the shin bone (the tibial metaphysis). It is placed under fluoroscopy or high-resolution ultrasound.

A lumbar facet block numbs the medial branches of the dorsal rami (small nerves to the spine’s joints). The spot is where the superior articular process meets the transverse process.

Both do the same thing: they interrupt a wire. Neither one changes the load that joint carries. Neither one changes the chemistry the joint sits in.

That difference is the whole article, because three things keep running while the wire is quiet:

• Load. Extra body weight raises the squeezing force across a knee that is breaking down with every single step.
• Inflammation. Fat tissue (adipose tissue) is not dead padding. It keeps a low-grade inflammatory state running through the whole body.
• Repair. High blood sugar slows tissue repair.

An injection silences the wire while the generator keeps running.

Why do pain injections stop working over time?

This is the part patients feel and are rarely given language for.

Say the signal generator is still being fed — by load, by inflammation and by glucose. Then a block is doing precisely what a block does. It buys a set stretch of quiet in a joint whose real situation has not changed. When the medication is gone, the same knee sends the same signal. So the stairs come back.

And in a high-volume pain practice, nobody is paid to ask why the same knee sends the same signal every ninety days. The block is a billable event. The question is not. You come back, the gap shortens, and after two years you have a thick chart and the same stairs.

Being told this is not the same as being told it is your fault. It is a statement about design: what the procedure was aimed at, and what it was not.

What has to be ruled out before a pain injection?

None of the reasoning above matters if the wrong structure is being treated. A short list has to be settled before a needle makes sense at all:

• Hip osteoarthritis refers pain into the knee. Hip internal rotation gets tested first.
• Crystal disease and inflammatory arthritis need lab work. And if the joint is swollen with fluid (effused), the answer is aspiration (draining it), not an ablation.
• Back pain is “nonspecific” only after red flags are excluded: fever, progressive weakness, saddle numbness, bowel or bladder change, and unexplained weight loss.

Diagnosis first. Every grade that follows assumes the generator has actually been found.

Grading the plan out loud: core, adjunctive, emerging, untested

Two models compete for your attention, and both of them sell certainty. The procedure model sells the next injection. The wellness model sells a diet, a stack of supplements, a red light panel, and a promise that inflammation is the root of everything. Neither one usually shows you the grading behind the claim.

So here is the grading. Four words, applied one at a time. We start with the pillar that is hardest to grade honestly, because it is the one being sold to you here.

Pillar one — the procedure itself: core, but for diagnosis

Its established value is diagnostic. Done correctly, a block tells the physician which structure is making the signal. Its treatment value is real but time-limited, and the durability data are thinner. We offer no graded efficacy citation here for that durability, on purpose. The standard we apply to a supplement company applies to the procedure too.

A diagnostic block that reproduces and then abolishes your pain is evidence, not proof, that the targeted nerve carries the signal. As stated in the video, a single block is wrong somewhere between a fifth and a third of the time. That is a deliberately general range, not a figure from a specific trial. That is why a second block with an anesthetic of a different duration comes before any ablation, and the relief has to track the drug. If the relief does not track the drug, the block was a false positive. The honest move is to stop, not to ablate.

The risks, plainly. Bleeding. Infection. Nerve injury. Epidural hematoma or abscess (a blood or pus pocket near the spine). Dural puncture headache. In 2014 the U.S. Food and Drug Administration issued a Drug Safety Communication on epidural corticosteroid injection. It described rare catastrophic neurologic events, including spinal cord infarction, paralysis, stroke, vision loss, and death. After radiofrequency ablation: neuritis, dysesthesia, short-lived numbness or weakness, and burns. Corticosteroid raises blood sugar for days in people with diabetes. Repeated dosing carries adrenal suppression and bone loss. Inside the knee, it carries a signal of cartilage loss without added benefit. Do not start, stop, or change any medication without consulting your physician.

Pillar two — exercise and weight reduction: core therapy

The 2019 American College of Rheumatology and Arthritis Foundation guideline (Kolasinski and colleagues) strongly recommends exercise for knee and hip osteoarthritis in everyone, and weight loss for patients who are overweight or obese.[3] (Established.) For those patients this is not an add-on. It is core therapy, and the procedure is the add-on.

The number behind it comes from the IDEA trial (Messier and colleagues, JAMA, 2013). It randomized 454 adults aged 55 and older, body mass index 27 to 41, with knee osteoarthritis seen on X-ray.[1] At eighteen months the intensive diet-and-exercise arm had lost 11.4 percent of body weight. They reported knee pain of 3.6 on a 20-point WOMAC scale. The exercise-alone arm lost 2.0 percent and reported 4.7. That is a gap of 1.1 points out of 20 — at or below a minimally important difference. (Established finding, modest magnitude; it deserves to be quoted that way.)

Four qualifications belong in the same breath:

• Those numbers came from knees, on x-ray. The guideline covers the hip, but IDEA enrolled no hip patients. So for the hip there is a strong recommendation and no number.
• The benefit was measured at twelve to eighteen months, while the program was still running. Whether it holds afterward has never been tested. Sticking with it is the treatment, not a detail attached to it.
• IDEA’s diet was low-fat calorie restriction, not ketogenic.
• A ketogenic approach is adjunctive and untested in this setting. It needs supervision. On insulin or a sulfonylurea, it risks low blood sugar (hypoglycemia). With an SGLT2 inhibitor, it risks euglycemic ketoacidosis. It can also raise LDL. Do not start, stop, or change any medication without consulting your physician.

Pillar three — supplements and light: emerging, and one that is not even that

Specialized pro-resolving mediators made from omega-3 fatty acids are fascinating biology. But the human outcome data are not there. That is emerging, not established. And the same guideline that strongly recommends weight loss conditionally recommends against fish oil — the closest guideline-graded match available.[3] These products are sold without premarket review. They raise bleeding risk on an anticoagulant or antiplatelet drug. So tell us about every supplement before a needle goes anywhere near your spine.

The light is not emerging at all. Red and near-infrared devices at 660 to 850 nanometers are cleared only for temporary relief of minor muscle and joint pain and stiffness — not as a chronic pain protocol.

Pillar four — structured rehabilitation: modest, and specific about what was tested

The Cochrane review by Kamper and colleagues (2014) included 41 randomized trials and 6,858 participants. All had nonspecific chronic low back pain.[2] What it tested was multidisciplinary biopsychosocial rehabilitation: physical reconditioning delivered together with psychological and social or work pieces. Clinicians from different fields deliver it. Not a posture class. Not a home exercise sheet.

In the sixteen trials against usual care, long-term pain improvement was a standardized mean difference of 0.21 (95% CI 0.04 to 0.37), on moderate-to-low quality evidence — also at or below a minimally important difference. (A small effect, and a low-certainty one. The interval very nearly touches zero, and the size is below the threshold. The review’s own authors call the benefit modest. It is not an established size you can plan around.)

The combination — untested

Here is the sentence nobody selling a protocol says out loud. Every figure above came from studies with no injection anywhere in the design. No trial has compared a procedure plus metabolic care against the procedure alone. The reason to combine them is mechanistic and reasonable. It is also unproven. (Untested. If anyone tells you it is established, they are selling.)

What the standard approach misses — in both directions

Symptom-control medication and image-guided procedures do something truly useful. They reduce suffering now. And a well-placed diagnostic block answers a question no scan can answer. The physicians offering them are not doing anything wrong.

What they do not do is change load, inflammation, or glucose.

The mirror-image failure comes from people who look like allies. They sell a metabolic or wellness plan as the root cause of everything, with no grading behind it. They offer it to someone whose pain generator was never found in the first place.

The failure in both directions is the same failure — certainty offered without a grade attached.

What should you do when your injections stop working?

If your procedures worked and then stopped working, the useful next question is not which injection comes next. It is: which part of my plan is core, which is adjunctive, and which is a hypothesis?

An evaluation that takes that question seriously does four things. It finds the actual pain generator before treating it. It confirms that finding with a repeat block using a different-duration anesthetic before anything is ablated. It treats exercise and, where needed, weight reduction as core therapy, not as advice tacked on at the end. And it labels the adjunctive and emerging pieces as exactly that, out loud, before you pay for them.

Want to see how the procedure half is built? Which procedures exist, what each one is diagnostic for, and how candidacy is decided? The overview of interventional pain management and the diagnostic sequence behind it walks through it procedure by procedure.

A composite picture, not a testimonial

What follows is a composite — a picture assembled from many patients with this condition, not one person’s chart.

Late fifties. Knee osteoarthritis on X-ray, body mass index in the mid-thirties, low back pain past a year, an A1c in the prediabetic range, four prior injections elsewhere. Two diagnostic genicular blocks with anesthetics of different duration agreed that the knee capsule was a real pain generator. That bought a working window. Inside that window the hard part began, and it was not the needle. It was eighteen months of supervised weight reduction and progressive loading, with a physician watching the medications. Weight came down near ten percent, and it took eleven months. There were two long plateaus and one full slide back over a holiday season. Pain did not vanish. It moved from constant to situational. Stairs stopped being an event.

Hold that loosely. This is a practice observation, not a trial result, and no trial has tested this combination. The claim will not be smuggled back in through a story. Individual results vary. What can honestly be said is narrower than a cure. A generator running quieter. A wire that stays quiet longer, for reasons that cannot yet be proven. And a person no longer planning a calendar around the next injection.

Frequently asked questions

The office, hours and directions are on our Locations page.

Key takeaways

• A genicular or facet block interrupts the wire carrying your pain signal. It does not change joint load, inflammation in the body, or blood glucose. That is why the quiet window can shrink rather than grow.
• Everything cited here applies to knee and hip osteoarthritis and to nonspecific low back pain past twelve weeks. Nothing else.
• Exercise is strongly recommended core therapy for everyone with knee or hip osteoarthritis, and weight loss is for those who are overweight or obese. But the measured pain gap in the IDEA trial was 1.1 points on a 20-point scale. That is at or below a minimally important difference, in knees only, while the program ran.
• Multidisciplinary rehabilitation beat usual care for chronic low back pain by a standardized mean difference of only 0.21. The evidence was moderate-to-low quality. That is a small, low-certainty effect, not a size to plan around.
• Pro-resolving mediator supplements are emerging. The same guideline conditionally recommends against fish oil. 660–850 nm light is cleared only for temporary minor relief. A ketogenic diet is adjunctive and untested here.
• No trial has tested a procedure plus metabolic care against the procedure alone. So ask which part of your plan is core, which is adjunctive, and which is a hypothesis.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. To have your pain generator identified before the next procedure is scheduled, call (314) 481-5000 or text (314) 886-5902.

References

1. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263-1273. PMID 24065013. PubMed
2. Kamper SJ, Apeldoorn AT, Chiarotto A, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014;(9):CD000963. PMID 25180773. PubMed
3. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162. PMID 31908149. PubMed

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP